Market Herald logo

Subscribe

Be the first with the news that moves the market
  • CareSpan (CSPN) offers integrated digital tools to empower patients and health care practitioners
  • Its flagship Clinic-in-the-Cloud workflow platform supports both in-person and telehealth care
  • Melissa Magstadt, CEO of American APN, CareSpan’s nurse practitioner network, spoke with Daniella Atkinson about how the company is working with nurse practitioners to address U.S. health care shortages
  • CareSpan is a health care technology and services company improving patient outcomes through integrated digital care
  • CareSpan Health (CSPN) opened trading at $0.20 per share

CareSpan (CSPN) offers integrated digital tools to empower patients and health care practitioners.

Its proprietary Clinic-in-the-Cloud workflow platform integrates remote patient monitoring, diagnostic tools, electronic health records, as well as e-prescribing and lab ordering whether for in-person or telehealth care.

The company is using its platform to build provider networks across the U.S. that deliver primary, chronic, urgent and behavioral health care to underserved populations.

Melissa Magstadt, CEO of American APN, CareSpan’s nurse practitioner network, spoke with Daniella Atkinson about how the company is addressing U.S. shortages in primary, chronic and urgent care.

Topics discussed include nurse practitioners’ key role in meeting the demand for quality health care and how CareSpan technology enhances their service now and into the future.

CareSpan is a health care technology and services company improving patient outcomes through integrated digital care.

CareSpan Health (CSPN) opened trading at $0.20 per share.


More From The Market Herald

" Innocan Pharma (CSE:INNO) files patent application entitled “compositions for treatment of hair loss”

Innocan Pharma (INNO) has filed a new patent application for a composition to treat and prevent hair loss.
The Market Herald Video

" Green River Gold (CSE:CCR) provides update on the 2022 exploration program at its Quesnel Project

Green River Gold (CCR) has updated progress on the 2022 exploration program at its Quesnel Nickel/Magnesium/Talc Project.

" Differentiated technologies dominate this week’s market movers

With inflation reaching 8.1 per cent in June, investors are keen on protecting their portfolios from rising costs.

" PharmAla Biotech (CSE:MDMA) to be the exclusive supplier for GMP LaNeo and Engineering MDMA

“Our hope is this will streamline and further propel our client’s research efforts to uncover and optimize the key properties of psychedelics and